GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » Short-Term Debt & Capital Lease Obligation

Avivagen (TSXV:VIV) Short-Term Debt & Capital Lease Obligation : C$6.14 Mil (As of Jul. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Avivagen Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Avivagen's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2023 was C$6.14 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Avivagen's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2023 was C$1.10 Mil.


Avivagen Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Avivagen's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Short-Term Debt & Capital Lease Obligation Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.75 1.54 5.39 0.84

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.84 1.00 5.44 6.14

Avivagen Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Avivagen Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Avivagen's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (TSXV:VIV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » Short-Term Debt & Capital Lease Obligation
Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (TSXV:VIV) Headlines

From GuruFocus

4Q20 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 02-24-2021

2Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 07-26-2022

3Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 10-26-2022

2Q20 Results: Telefônica Brasil S.A.

By PRNewswire PRNewswire 07-29-2020

1Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-12-2021

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 07-09-2022

A Trio of High Earnings Return Stocks

By Alberto Abaterusso Alberto Abaterusso 02-04-2021

1Q20 Results: Telefônica Brasil S.A.

By PRNewswire PRNewswire 05-06-2020

DORCHESTER WEALTH MANAGEMENT Co Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-04-2022